Company news

ImmunityBio, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

NantKwest Announces Phase 1 Results for First-in-Human PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) in Patients with Locally Advanced or Metastatic Solid Cancers

December 1, 2019

NantKwest Hosting Key Opinion Leader Meeting on Novel Immunotherapeutic Approaches to Address the Unmet Medical Needs of Patients with Merkel Cell Carcinoma, Triple-Negative Breast Cancer and Solid Tumors

November 26, 2019

NantKwest Announces Presentation of Positive Phase 2 Clinical Data of Natural Killer Cell Therapy in Metastatic Merkel Cell Carcinoma at SITC 2019

November 6, 2019

← Newer news releases

Decks

The 5 newest of 10 decks. Every deck is listed under its year.